If you need more lookups,
subscriptions start at $34 USD/month.
Mary Bell Location
Dedham, MA, US
Mary Bell Work
VP, Program and Alliance Management @ (April 2012 - Present)
Consultant @ Biotechnology & Life Sciences (January 2012 - April 2012)
VP, Portfolio, Program and Alliance Management + Member, Executive Management Team @ Anchor Therapeutics (January 2010 - January 2011)
Director, Project Management @ (January 2002 - August 2010)
Senior Project Manager @ (January 1998 - January 2002)
Project Manager @ (January 1991 - January 1998)
Manager, Scientific Affairs @ Genetics Institute (January 1989 - January 1991)
Mary Bell Education
Wellesley College
BA
Mary Bell Skills
Clinical Trials
Translational Medicine
Small Molecules
CRO
Drug Product
Antibodies
Infectious Diseases
Portfolio Management
Commercialization
Clinical Research
Assay Development
CTMS
Biotechnology
Regulatory Affairs
Combination Products Drugs + Devices
Strategic Planning
Medical Devices
Strategy
Drug Discovery
Lifesciences
Program Management
Oncology
Drug Development
Pharmaceutics
Cross Functional Team Leadership
Clinical Development
GCP
Biologics
Regulatory Submissions
Vaccines
Pharmacology
CMC
Alliance Management
Project Management
Peptides
Pharmaceutical Industry
Proteins
Strategic Alliances
Biochemistry
Technology Transfer
Therapeutic Areas
GLP
Biomarkers
R&d
Protein Chemistry
FDA
21 CFR Part 11
Biomarker Discovery
IND
Biopharmaceuticals
Combination Products
Mary Bell Summary
Mary Bell, based in Dedham, MA, US, is currently a VP, Program and Alliance Management at Nimbus Therapeutics. Mary Bell brings experience from previous roles at Biotechnology & Life Sciences, Anchor Therapeutics and Pfizer (acquired Wyeth & Genetics Institute). Mary Bell holds a BA @ Wellesley College. With a robust skill set that includes Clinical Trials, Translational Medicine, Small Molecules, CRO, Drug Product and more. Mary Bell has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Mary Bell?
Find contact details for 700 million professionals.